Pregnancy outcome in fetuses with increased nuchal translucency and normal karyotype
- 27 March 2002
- journal article
- Published by Wiley in Prenatal Diagnosis
- Vol. 22 (5) , 345-349
- https://doi.org/10.1002/pd.321
Abstract
Objective This study was conducted to evaluate pregnancy outcome and mid‐ and long‐term prognosis of cases with nuchal translucency ≥4 mm and normal karyotype. Methods Retrospective analysis of 160 cases who presented with a nuchal translucency ≥4 mm when the CRL was between 45 and 84 mm was undertaken. Cystic hygromas were excluded. When the karyotype was normal a detailed anomaly scan was performed at 20 to 24 weeks followed by serial ultrasound examination. Clinical examination of the neonates was performed by a paediatrician. Long‐term follow‐up was completed through a questionnaire filled in by parents, GPs and paediatricians. Results 160 fetuses had an NT ≥4 mm. 44.3% had an abnormal karyotype. Of the 55.7% with normal karyotypes, 74 % did not show any abnormalities on follow‐up ultrasound scan. Mid‐ and long‐term outcome was known in 91% of the cases. 6.4% had a malformation diagnosed only at birth. Among the normal neonates, 11.1% are considered to have a significant neurological handicap or orthopaedic problems at 12 to 72 months of age. Conclusion In an unselected population, NT ≥4 mm is associated with a high incidence of chromosomal and non chromosomal abnormalities. Even when the fetal karyotype and serial ultrasound examinations are considered to be normal, the risk of fetal malformation and developmental delay should not be underestimated. Copyright © 2002 John Wiley & Sons, Ltd.Keywords
This publication has 14 references indexed in Scilit:
- Fetal nuchal translucency and normal chromosomes: a long‐term follow‐up studyUltrasound in Obstetrics & Gynecology, 2001
- Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimesterUltrasound in Obstetrics & Gynecology, 2001
- Limitations of using first‐trimester nuchal translucency measurement in routine screening for major congenital heart defectsUltrasound in Obstetrics & Gynecology, 2001
- Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetusesUltrasound in Obstetrics & Gynecology, 2001
- Screening for Down's syndrome by fetal nuchal translucency measurement in a high‐risk populationUltrasound in Obstetrics & Gynecology, 1998
- Outcome and early childhood follow‐up of chromosomally normal fetuses with increased nuchal translucency at 10–14 weeks' gestationUltrasound in Obstetrics & Gynecology, 1998
- Outcome of fetuses with enlarged nuchal translucency and normal karyotypeUltrasound in Obstetrics & Gynecology, 1998
- Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10–14 weeks of gestationUltrasound in Obstetrics & Gynecology, 1998
- FETAL OUTCOME IN NUCHAL TRANSLUCENCY WITH EMPHASIS ON NORMAL FETAL KARYOTYPEPrenatal Diagnosis, 1996
- Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucencyUltrasound in Obstetrics & Gynecology, 1995